Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2014-01

AUTHORS

Daniel Espes, Joey Lau, Per-Ola Carlsson

ABSTRACT

AIMS/HYPOTHESIS: The hormone betatrophin was recently described as a potent stimulator of beta cell proliferation in mice. Insulin resistance, but not insulin deficiency, caused upregulation of betatrophin expression. If these findings were found to be fully applicable in humans, this would open up the possibility of future betatrophin treatment in type 1 diabetes. The present study measured for the first time betatrophin concentrations in humans and tested the hypothesis that there would be no difference in circulating betatrophin concentrations between patients with type 1 diabetes and healthy individuals. METHODS: Betatrophin concentrations in plasma of 33 patients with type 1 diabetes and 24 age-matched healthy controls were measured by ELISA. The study participants were characterised for blood lipids, BMI, plasma glucose and HbA1c, and, for the diabetic patients, their insulin requirements and any residual C-peptide concentrations. RESULTS: Plasma betatrophin concentrations were normally ~300 pg/ml, but were approximately doubled in patients with type 1 diabetes. In the patients, there were no correlations between betatrophin and age, blood lipids, BMI, glucose control or insulin requirement, whereas in controls betatrophin levels increased with age. BMI, blood pressure and triacylglycerol, LDL-cholesterol and HDL-cholesterol levels were similar in patients and healthy controls. CONCLUSIONS/INTERPRETATION: Circulating concentrations of betatrophin are increased in type 1 diabetes in contrast with what was recently described in an insulin-deficient mouse model. However, increased betatrophin concentrations do not protect against loss of C-peptide. Betatrophin treatment in type 1 diabetes would therefore probably not be successful without the use of supraphysiological doses or a combination with immune regulatory treatment. More... »

PAGES

50-53

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00125-013-3071-1

DOI

http://dx.doi.org/10.1007/s00125-013-3071-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1002385270

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24078058


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Angiopoietin-like Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "C-Peptide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetes Mellitus, Type 1", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Enzyme-Linked Immunosorbent Assay", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Peptide Hormones", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Uppsala University", 
          "id": "https://www.grid.ac/institutes/grid.8993.b", 
          "name": [
            "Department of Medical Cell Biology, Uppsala University, Husargatan 3, Box 571, SE-75123, Uppsala, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Espes", 
        "givenName": "Daniel", 
        "id": "sg:person.01350245556.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01350245556.73"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Uppsala University", 
          "id": "https://www.grid.ac/institutes/grid.8993.b", 
          "name": [
            "Department of Medical Cell Biology, Uppsala University, Husargatan 3, Box 571, SE-75123, Uppsala, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lau", 
        "givenName": "Joey", 
        "id": "sg:person.0706531007.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0706531007.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Uppsala University", 
          "id": "https://www.grid.ac/institutes/grid.8993.b", 
          "name": [
            "Department of Medical Cell Biology, Uppsala University, Husargatan 3, Box 571, SE-75123, Uppsala, Sweden", 
            "Department of Medical Sciences, Uppsala University, Uppsala, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Carlsson", 
        "givenName": "Per-Ola", 
        "id": "sg:person.01216166160.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01216166160.54"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1073/pnas.1217552109", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021127204"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/db10-0676", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023476378"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-013-2904-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029808455", 
          "https://doi.org/10.1007/s00125-013-2904-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-013-2904-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029808455", 
          "https://doi.org/10.1007/s00125-013-2904-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-013-2904-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029808455", 
          "https://doi.org/10.1007/s00125-013-2904-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.bbrc.2012.07.038", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031784683"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.20363", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042011474"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-007-0794-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043012260", 
          "https://doi.org/10.1007/s00125-007-0794-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-007-0794-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043012260", 
          "https://doi.org/10.1007/s00125-007-0794-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-007-0794-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043012260", 
          "https://doi.org/10.1007/s00125-007-0794-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/dc11-1236", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043116933"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-010-1817-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043959469", 
          "https://doi.org/10.1007/s00125-010-1817-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-010-1817-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043959469", 
          "https://doi.org/10.1007/s00125-010-1817-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-010-1817-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043959469", 
          "https://doi.org/10.1007/s00125-010-1817-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diabetes.49.4.626", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049639052"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.cell.2013.04.008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052227980"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-01", 
    "datePublishedReg": "2014-01-01", 
    "description": "AIMS/HYPOTHESIS: The hormone betatrophin was recently described as a potent stimulator of beta cell proliferation in mice. Insulin resistance, but not insulin deficiency, caused upregulation of betatrophin expression. If these findings were found to be fully applicable in humans, this would open up the possibility of future betatrophin treatment in type 1 diabetes. The present study measured for the first time betatrophin concentrations in humans and tested the hypothesis that there would be no difference in circulating betatrophin concentrations between patients with type 1 diabetes and healthy individuals.\nMETHODS: Betatrophin concentrations in plasma of 33 patients with type 1 diabetes and 24 age-matched healthy controls were measured by ELISA. The study participants were characterised for blood lipids, BMI, plasma glucose and HbA1c, and, for the diabetic patients, their insulin requirements and any residual C-peptide concentrations.\nRESULTS: Plasma betatrophin concentrations were normally ~300 pg/ml, but were approximately doubled in patients with type 1 diabetes. In the patients, there were no correlations between betatrophin and age, blood lipids, BMI, glucose control or insulin requirement, whereas in controls betatrophin levels increased with age. BMI, blood pressure and triacylglycerol, LDL-cholesterol and HDL-cholesterol levels were similar in patients and healthy controls.\nCONCLUSIONS/INTERPRETATION: Circulating concentrations of betatrophin are increased in type 1 diabetes in contrast with what was recently described in an insulin-deficient mouse model. However, increased betatrophin concentrations do not protect against loss of C-peptide. Betatrophin treatment in type 1 diabetes would therefore probably not be successful without the use of supraphysiological doses or a combination with immune regulatory treatment.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00125-013-3071-1", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1001482", 
        "issn": [
          "0012-186X", 
          "1432-0428"
        ], 
        "name": "Diabetologia", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "57"
      }
    ], 
    "name": "Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes", 
    "pagination": "50-53", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "0b5b4eda7ff5cf084b64a2f1a9f1bd54bd01a289ddb7873fb953225a55800633"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24078058"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0006777"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00125-013-3071-1"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1002385270"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00125-013-3071-1", 
      "https://app.dimensions.ai/details/publication/pub.1002385270"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T09:57", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000347_0000000347/records_89807_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs00125-013-3071-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00125-013-3071-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00125-013-3071-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00125-013-3071-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00125-013-3071-1'


 

This table displays all metadata directly associated to this object as RDF triples.

157 TRIPLES      21 PREDICATES      49 URIs      31 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00125-013-3071-1 schema:about N2e033b6123ef4c528fe71f533f4aedc3
2 N50a780d41e6b4016b7827494303c8994
3 N58b7f1a83f514494897fa22d1cab175e
4 N5f7487dd3ca14301b2127342b7d843de
5 N6d41899ca0614f9c87f0bac1223625b1
6 N8b118a242f7a455193d53ba757e3adb3
7 Na7a9bce4191849efa663dff7c0997e31
8 Nbc148fc736c340ab8fdf0e68b2e323e5
9 Nbe6c4eea3b9f42eba824a20d8c4b4537
10 Nda11d61a6cd54b56b17aa4ace84775fa
11 anzsrc-for:11
12 anzsrc-for:1103
13 schema:author Ncb180c92550b4e67bcc778a7025955c8
14 schema:citation sg:pub.10.1007/s00125-007-0794-x
15 sg:pub.10.1007/s00125-010-1817-6
16 sg:pub.10.1007/s00125-013-2904-2
17 https://doi.org/10.1002/ijc.20363
18 https://doi.org/10.1016/j.bbrc.2012.07.038
19 https://doi.org/10.1016/j.cell.2013.04.008
20 https://doi.org/10.1073/pnas.1217552109
21 https://doi.org/10.2337/db10-0676
22 https://doi.org/10.2337/dc11-1236
23 https://doi.org/10.2337/diabetes.49.4.626
24 schema:datePublished 2014-01
25 schema:datePublishedReg 2014-01-01
26 schema:description AIMS/HYPOTHESIS: The hormone betatrophin was recently described as a potent stimulator of beta cell proliferation in mice. Insulin resistance, but not insulin deficiency, caused upregulation of betatrophin expression. If these findings were found to be fully applicable in humans, this would open up the possibility of future betatrophin treatment in type 1 diabetes. The present study measured for the first time betatrophin concentrations in humans and tested the hypothesis that there would be no difference in circulating betatrophin concentrations between patients with type 1 diabetes and healthy individuals. METHODS: Betatrophin concentrations in plasma of 33 patients with type 1 diabetes and 24 age-matched healthy controls were measured by ELISA. The study participants were characterised for blood lipids, BMI, plasma glucose and HbA1c, and, for the diabetic patients, their insulin requirements and any residual C-peptide concentrations. RESULTS: Plasma betatrophin concentrations were normally ~300 pg/ml, but were approximately doubled in patients with type 1 diabetes. In the patients, there were no correlations between betatrophin and age, blood lipids, BMI, glucose control or insulin requirement, whereas in controls betatrophin levels increased with age. BMI, blood pressure and triacylglycerol, LDL-cholesterol and HDL-cholesterol levels were similar in patients and healthy controls. CONCLUSIONS/INTERPRETATION: Circulating concentrations of betatrophin are increased in type 1 diabetes in contrast with what was recently described in an insulin-deficient mouse model. However, increased betatrophin concentrations do not protect against loss of C-peptide. Betatrophin treatment in type 1 diabetes would therefore probably not be successful without the use of supraphysiological doses or a combination with immune regulatory treatment.
27 schema:genre research_article
28 schema:inLanguage en
29 schema:isAccessibleForFree true
30 schema:isPartOf N9de6e3ac13b740fba080eb7b0f5f5bbc
31 Ne56dcedba6b8421eae34d818b4fd021d
32 sg:journal.1001482
33 schema:name Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes
34 schema:pagination 50-53
35 schema:productId N138940d9b074432d8bb7113c83b0e8af
36 N3cb58669b8f14900b10a950bc56876d7
37 Nab45e1dee2e447109b3ebfd7192a94db
38 Nbe5390d15ebb4c68ababccb18a0ac07f
39 Ne8844590939040b496d4fa085338ed00
40 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002385270
41 https://doi.org/10.1007/s00125-013-3071-1
42 schema:sdDatePublished 2019-04-11T09:57
43 schema:sdLicense https://scigraph.springernature.com/explorer/license/
44 schema:sdPublisher N5257a9dbab8f42cb88a70713c423ce5a
45 schema:url https://link.springer.com/10.1007%2Fs00125-013-3071-1
46 sgo:license sg:explorer/license/
47 sgo:sdDataset articles
48 rdf:type schema:ScholarlyArticle
49 N138940d9b074432d8bb7113c83b0e8af schema:name pubmed_id
50 schema:value 24078058
51 rdf:type schema:PropertyValue
52 N2e033b6123ef4c528fe71f533f4aedc3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
53 schema:name C-Peptide
54 rdf:type schema:DefinedTerm
55 N2f031a3e2f814c048951f213dd82f7ac rdf:first sg:person.0706531007.81
56 rdf:rest Nf5ac03f58f424a78b756c625b2d8ce22
57 N3cb58669b8f14900b10a950bc56876d7 schema:name nlm_unique_id
58 schema:value 0006777
59 rdf:type schema:PropertyValue
60 N50a780d41e6b4016b7827494303c8994 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
61 schema:name Humans
62 rdf:type schema:DefinedTerm
63 N5257a9dbab8f42cb88a70713c423ce5a schema:name Springer Nature - SN SciGraph project
64 rdf:type schema:Organization
65 N58b7f1a83f514494897fa22d1cab175e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
66 schema:name Adult
67 rdf:type schema:DefinedTerm
68 N5f7487dd3ca14301b2127342b7d843de schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
69 schema:name Enzyme-Linked Immunosorbent Assay
70 rdf:type schema:DefinedTerm
71 N6d41899ca0614f9c87f0bac1223625b1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Female
73 rdf:type schema:DefinedTerm
74 N8b118a242f7a455193d53ba757e3adb3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Angiopoietin-like Proteins
76 rdf:type schema:DefinedTerm
77 N9de6e3ac13b740fba080eb7b0f5f5bbc schema:volumeNumber 57
78 rdf:type schema:PublicationVolume
79 Na7a9bce4191849efa663dff7c0997e31 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Peptide Hormones
81 rdf:type schema:DefinedTerm
82 Nab45e1dee2e447109b3ebfd7192a94db schema:name readcube_id
83 schema:value 0b5b4eda7ff5cf084b64a2f1a9f1bd54bd01a289ddb7873fb953225a55800633
84 rdf:type schema:PropertyValue
85 Nbc148fc736c340ab8fdf0e68b2e323e5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Young Adult
87 rdf:type schema:DefinedTerm
88 Nbe5390d15ebb4c68ababccb18a0ac07f schema:name dimensions_id
89 schema:value pub.1002385270
90 rdf:type schema:PropertyValue
91 Nbe6c4eea3b9f42eba824a20d8c4b4537 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Male
93 rdf:type schema:DefinedTerm
94 Ncb180c92550b4e67bcc778a7025955c8 rdf:first sg:person.01350245556.73
95 rdf:rest N2f031a3e2f814c048951f213dd82f7ac
96 Nda11d61a6cd54b56b17aa4ace84775fa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Diabetes Mellitus, Type 1
98 rdf:type schema:DefinedTerm
99 Ne56dcedba6b8421eae34d818b4fd021d schema:issueNumber 1
100 rdf:type schema:PublicationIssue
101 Ne8844590939040b496d4fa085338ed00 schema:name doi
102 schema:value 10.1007/s00125-013-3071-1
103 rdf:type schema:PropertyValue
104 Nf5ac03f58f424a78b756c625b2d8ce22 rdf:first sg:person.01216166160.54
105 rdf:rest rdf:nil
106 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
107 schema:name Medical and Health Sciences
108 rdf:type schema:DefinedTerm
109 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
110 schema:name Clinical Sciences
111 rdf:type schema:DefinedTerm
112 sg:journal.1001482 schema:issn 0012-186X
113 1432-0428
114 schema:name Diabetologia
115 rdf:type schema:Periodical
116 sg:person.01216166160.54 schema:affiliation https://www.grid.ac/institutes/grid.8993.b
117 schema:familyName Carlsson
118 schema:givenName Per-Ola
119 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01216166160.54
120 rdf:type schema:Person
121 sg:person.01350245556.73 schema:affiliation https://www.grid.ac/institutes/grid.8993.b
122 schema:familyName Espes
123 schema:givenName Daniel
124 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01350245556.73
125 rdf:type schema:Person
126 sg:person.0706531007.81 schema:affiliation https://www.grid.ac/institutes/grid.8993.b
127 schema:familyName Lau
128 schema:givenName Joey
129 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0706531007.81
130 rdf:type schema:Person
131 sg:pub.10.1007/s00125-007-0794-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1043012260
132 https://doi.org/10.1007/s00125-007-0794-x
133 rdf:type schema:CreativeWork
134 sg:pub.10.1007/s00125-010-1817-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043959469
135 https://doi.org/10.1007/s00125-010-1817-6
136 rdf:type schema:CreativeWork
137 sg:pub.10.1007/s00125-013-2904-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029808455
138 https://doi.org/10.1007/s00125-013-2904-2
139 rdf:type schema:CreativeWork
140 https://doi.org/10.1002/ijc.20363 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042011474
141 rdf:type schema:CreativeWork
142 https://doi.org/10.1016/j.bbrc.2012.07.038 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031784683
143 rdf:type schema:CreativeWork
144 https://doi.org/10.1016/j.cell.2013.04.008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052227980
145 rdf:type schema:CreativeWork
146 https://doi.org/10.1073/pnas.1217552109 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021127204
147 rdf:type schema:CreativeWork
148 https://doi.org/10.2337/db10-0676 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023476378
149 rdf:type schema:CreativeWork
150 https://doi.org/10.2337/dc11-1236 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043116933
151 rdf:type schema:CreativeWork
152 https://doi.org/10.2337/diabetes.49.4.626 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049639052
153 rdf:type schema:CreativeWork
154 https://www.grid.ac/institutes/grid.8993.b schema:alternateName Uppsala University
155 schema:name Department of Medical Cell Biology, Uppsala University, Husargatan 3, Box 571, SE-75123, Uppsala, Sweden
156 Department of Medical Sciences, Uppsala University, Uppsala, Sweden
157 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...